Lassa Fever Treatment Market Outlook:
Lassa Fever Treatment Market size was over USD 657.01 million in 2025 and is projected to reach USD 1.53 billion by 2035, growing at around 8.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of lassa fever treatment is evaluated at USD 709.05 million.
The growth of the market can be attributed to the growing cases of fever across the world is projected to promote market growth. According to the data by the World Health Organization (WHO), 1 in every 5 Lassa fever infections result in severe infection in organs. Moreover, in 80% of cases, no symptoms are reported. Symptoms can vary from mild symptoms, such as nausea, and vomiting, to severe symptoms, such as deafness, seizure, and coma. As per another report by the WHO, deafness occurs in 25% of the cases of Lassa fever.
In addition, there has been an increasing incidence of Lassa fever, backed by a lack of sanitation and proper healthcare facilities. The major cause of Lassa fever is the consumption of food or water contaminated with rodent urine or faces. According to the data by UNICEF, 5 out of 10 people did not have access to safe sanitation services, in 2020.
